This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bassetti, M.
Right arrow Articles by Andriole, V. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bassetti, M.
Right arrow Articles by Andriole, V. T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2002, p. 234-238, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.234-238.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Antimicrobial Activities of BMS-284756 Compared with Those of Fluoroquinolones and ß-Lactams against Gram-Positive Clinical Isolates

Matteo Bassetti,1* Louise M. Dembry,1,2 Patricia A. Farrel,2 Deborah A. Callan,2 and Vincent T. Andriole1

Yale University School of Medicine,1 Yale-New Haven Hospital New Haven, Connecticut2

Received 27 April 2001/ Returned for modification 30 July 2001/ Accepted 5 October 2001

The in vitro antibacterial activity of BMS-284756 was compared to those of ciprofloxacin, gatifloxacin, moxifloxacin, ceftriaxone, imipenem, piperacillin-tazobactam, and amoxicillin-clavulanic acid against 492 gram-positive clinical isolates. BMS-284756 was the most-active agent against Streptococcus pneumoniae, Streptococcus viridans, beta-hemolytic streptococci, methicillin-sensitive and -resistant Staphylococcus aureus, methicillin-sensitive and -resistant coagulase-negative staphylococci, and enterococci.


* Corresponding author. Mailing address: Clinica Malattie Infettive, Universitá di Genova, Ospedale San Martino, Largo R. Benzi, 10, 16132 Genova, Italy. Phone: 39 010 5552668. Fax: 39 010 3537680. E-mail: mattba{at}tin.it.


Antimicrobial Agents and Chemotherapy, January 2002, p. 234-238, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.234-238.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Krishna, G., Kisicki, J. C., Olsen, S., Grasela, D. M., Wang, Z. (2007). The Effect of Omeprazole on the Bioavailability and Safety of Garenoxacin in Healthy Volunteers. J Clin Pharmacol 47: 628-632 [Abstract] [Full Text]  
  • Anguita-Alonso, P., Rouse, M. S., Piper, K. E., Steckelberg, J. M., Patel, R. (2006). Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.. Antimicrob. Agents Chemother. 50: 1263-1267 [Abstract] [Full Text]  
  • Christiansen, K. J., Bell, J. M., Turnidge, J. D., Jones, R. N. (2004). Antimicrobial Activities of Garenoxacin (BMS 284756) against Asia-Pacific Region Clinical Isolates from the SENTRY Program, 1999 to 2001. Antimicrob. Agents Chemother. 48: 2049-2055 [Abstract] [Full Text]  
  • Liebetrau, A., Rodloff, A. C., Behra-Miellet, J., Dubreuil, L. (2003). In Vitro Activities of a New Des-Fluoro(6) Quinolone, Garenoxacin, against Clinical Anaerobic Bacteria. Antimicrob. Agents Chemother. 47: 3667-3671 [Abstract] [Full Text]  
  • Credito, K. L., Jacobs, M. R., Appelbaum, P. C. (2003). Time-Kill Studies of the Antianaerobe Activity of Garenoxacin Compared with Those of Nine Other Agents. Antimicrob. Agents Chemother. 47: 1399-1402 [Abstract] [Full Text]  
  • Hecht, D. W., Osmolski, J. R. (2003). Activities of Garenoxacin (BMS-284756) and Other Agents against Anaerobic Clinical Isolates. Antimicrob. Agents Chemother. 47: 910-916 [Abstract] [Full Text]  
  • Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2003). Postantibiotic Effects of Garenoxacin (BMS-284756) against 12 Gram-Positive or -Negative Organisms. Antimicrob. Agents Chemother. 47: 1140-1142 [Abstract] [Full Text]